At ASDS 2025, Galderma unveiled pivotal new data from its range of pioneering Restylane ® hyaluronic acid (HA) injectables, highlighting its versatility in improving the chin profile with Restylane ...
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the U.S. FDA has approved Restylane Contour for the correction of temple hollowing in patients over the age of 21.
The approval was based on a multicenter, randomized, evaluator-blinded, split-hand study (N=89) which showed that treatment with Restylane Lyft resulted in a clinically meaningful improvement in the ...
Please provide your email address to receive an email when new articles are posted on . The FDA has granted market approval to Restylane Lyft with lidocaine for cheek augmentation and correction of ...
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that it presented new data from its Injectable Aesthetics portfolio and pipeline at the American Society for ...
Galderma receives US FDA approval for Restylane Contour for the correction of temple hollowing: Zug, Switzerland Tuesday, March 24, 2026, 18:00 Hrs [IST] Galderma, the pure-play d ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results